Go Deep
Dolby Laboratories, Inc.
Dolby Laboratories, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,777 | 24.9 | 2.13 | 0.02 | 5,673.60 |
| Oct 2026 | 20,819 | 24.7 | 2.10 | 0.02 | 5,559.65 |
| Oct 2026 | 20,802 | 24.8 | 2.12 | 0.02 | 5,557.84 |
| Oct 2026 | 20,759 | 25.0 | 2.13 | 0.02 | 5,586.71 |
| Oct 2026 | 20,580 | 25.7 | 2.21 | 0.02 | 5,776.48 |
| Oct 2026 | 20,659 | 25.5 | 2.17 | 0.02 | 5,678.16 |
| Oct 2026 | 20,559 | 26.0 | 2.21 | 0.02 | 5,789.49 |
| Oct 2026 | 20,446 | 26.5 | 2.26 | 0.02 | 5,908.01 |
| Oct 2026 | 20,427 | 26.6 | 2.27 | 0.02 | 5,913.28 |
| Oct 2026 | 20,359 | 26.9 | 2.29 | 0.02 | 5,973.05 |
Dolby Laboratories, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 304,995,000.0 | 395,630,000.0 | 346,706,000.0 | 307,024,000.0 |
| Net Profit | 28,602,000.0 | 94,915,000.0 | 53,327,000.0 | 49,332,000.0 |
| EPS | 0.3 | 1.0 | 0.6 | 0.5 |
Dolby Laboratories, Inc. Revenue & Profit: Last 4 Years
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Revenue | 1,349,130,000.0 | 1,273,721,000.0 | 1,299,744,000.0 | 1,253,793,000.0 |
| Net Profit | 255,018,000.0 | 261,825,000.0 | 200,656,000.0 | 184,087,000.0 |
| EPS | 2.7 | 2.7 | 2.1 | 1.8 |
Dolby Laboratories, Inc. Balance Sheet
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Total Assets | 3,227,760,000.0 | 3,109,928,000.0 | 2,979,766,000.0 | 2,689,548,000.0 |
| Total Liabilities | 595,814,000.0 | 623,035,000.0 | 607,582,000.0 | 438,528,000.0 |
| Total Equity | 2,622,557,000.0 | 2,477,162,000.0 | 2,355,100,000.0 | 2,246,183,000.0 |
Owes vs Owns
Dolby Laboratories, Inc. owed $0.18 for every $1 it owned in Jun 2026, up from $0.16 in Sep 2022.
| Period | Jun 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.18× | 0.18× | 0.20× | 0.20× | 0.16× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Dolby Laboratories, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Sep 2025
Cash & short-term investments 21.8%Receivables 15.9%Inventory 0.9%Fixed assets (tangible) 15.6%Intangible assets 28.7%Long-term investments 2.5%Other assets 14.6%
How it's funded — Sep 2025
Long-term debt 0.9%Payables 0.6%Other liabilities 16.7%Shareholders' equity 81.5%
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 702.6 | 482.0 | 884.5 | 809.3 |
| Receivables | 511.9 | 512.9 | 444.4 | 419.7 |
| Inventory | 30.4 | 33.7 | 35.6 | 23.5 |
| Fixed assets (tangible) | 503.8 | 518.2 | 521.8 | 560.0 |
| Intangible assets | 927.0 | 967.7 | 575.8 | 477.4 |
| Long-term investments | 80.2 | 89.3 | 97.8 | 102.5 |
| Other assets | 471.9 | 506.1 | 419.8 | 297.0 |
| Liabilities & equity | ||||
| Short-term debt | 10.4 | 12.2 | 13.6 | 13.3 |
| Long-term debt | 28.5 | 34.8 | 37.0 | 37.7 |
| Payables | 17.8 | 17.4 | 20.9 | 14.2 |
| Other liabilities | 539.1 | 558.7 | 536.0 | 373.4 |
| Shareholders' equity | 2,631.9 | 2,486.9 | 2,372.2 | 2,251.0 |
| Net tangible assets | 1,695.6 | 1,509.4 | 1,779.3 | 1,768.8 |
Dolby Laboratories, Inc. Cash Flow
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Operating Activities | 472,198,000.0 | 327,252,000.0 | 367,081,000.0 | 318,576,000.0 |
| Investing Activities | -10,586,000.0 | -286,292,000.0 | 54,206,000.0 | -295,935,000.0 |
| Financing Activities | -247,238,000.0 | -287,814,000.0 | -236,812,000.0 | -610,558,000.0 |